Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Apply expense trends to adjust your budget, making proactive changes that reflect shifting costs and priorities.
22,036 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
As volatility cools, the VIX holds near historically low levels while major indices chase new records. Earnings remai...
eXp Commercial announced the addition of Mario Alvarez Jr., a Southern California veteran with over $1B in career dea...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
JPMorgan cuts McDonald’s price target to $305 amid softer same-store-sales, signaling a shift toward efficiency at ex...
As housing demand cools, Home Depot and Lowe’s diverge on dividend resilience. Home Depot shows stronger cash flow an...
Bitcoin surged toward a crucial resistance level as news spread that trump just flew china and a tech-heavy delegatio...
April’s rent reading jumped 0.6% as the government finally catches up on a year of data, a quirk that has investors w...
Bitcoin jumped to an intraday high near $82,000 on Thursday after a Senate committee advanced the Clarity Act, then e...
Solana stands at a turning point as SOL tests a key price band. Traders are watching resistance near the $100 mark an...